For the Alzheimer's trial you mentioned that "cond
Post# of 148190
My question is this: Is that also true for the mssCRC trial? Is it possible that conditional approval on a phase 2 for that disease would make a phase 3 unnecessary?
If you mentioned this before my apologies, but I didn't see it mentioned whether mssCRC could skip phase 3